.After antibody-drug conjugate (ADC) specialist Seagen was sold to Pfizer in 2013 for an enormous $4...
.On the heels of a period 3 succeed that fell short to impress financiers, Ironwood Pharmaceuticals ...
.Do not stop Monte Rosa Therapies right now. The Boston-based biotech is having a ball after authori...
.Invite to recently's Chutes & Ladders, our roundup of substantial leadership hirings, firings an...
.Commemorating his firm's upsized initial public offering (IPO), Septerna chief executive officer Je...
.AbbVie has actually returned to the source of its own antipsychotic goliath Vraylar trying to find ...
.GenSight Biologics is full weeks away from losing amount of money. Once again. The biotech merely h...
.Monopar Therapeutics is actually bouncing back a medication from the dump of AstraZeneca's rare dis...
.With brand-new data out on Arcus Biosciences' speculative HIF-2a prevention, one group of professio...
.After developing a gene treatment relationship along with Dyno Therapies in 2020, Roche is back for...